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sh
MaOBJECTIVES The aim of this study was to assess adenosine infusion via a cannula in the back of the hand compared
with central venous access to achieve peak hyperemia during fractional ﬂow reserve (FFR).
BACKGROUND Adenosine is often used to induce maximal hyperemia when measuring FFR. The gold standard is
continuous infusion via a large central vein; however, the increasing use of the transradial route for angiography makes it
desirable to have an alternative route for adenosine. Peripheral venous access is frequently obtained in the hand, but
concern exists as to whether adenosine delivery from this site can achieve adequate vasodilation for accurate FFR
measurement. Our aim was to address this.
METHODS Subjects were selected from patients presenting for coronary angiography/intervention who required a
pressure-wire study. Subjects received intravenous adenosine infusion sequentially via 2 routes: ﬁrst, via a 20-gauge
hand cannula, and then, after a washout period, via a 5- or 6-F femoral venous sheath. Adenosine was administered at
140 mg/kg/min from each site. Data interpretation was blinded. Minimal FFR achieved with intravenous adenosine from
each infusion site was recorded as was the time to peak hyperemia.
RESULTS Paired (hand and femoral adenosine) recordings taken from 84 vessels in 61 patients were suitable for blinded
analysis. The mean FFR measured using adenosine administered via hand and femoral routes was 0.85 with an SD of 0.08
(intraclass correlation ¼ 0.986). Time to peak hyperemia was longer on average with hand-administered adenosine
compared with femoral adenosine administration (63 s vs. 43 s; mean difference, 22 s with a 95% conﬁdence interval:
18 s to 27 s; p < 0.0001). Formal comparison of FFR stability using Mann-Whitney analysis (2 tailed) gives p ¼ 0.43,
indicating no signiﬁcant evidence of a difference in stability between the 2 routes.
CONCLUSIONS Hand vein adenosine infusion produced FFR values very similar to those obtained using central femoral
vein adenosine administration, with no systematic bias toward higher or lower reading from 1 site. This has important
practical implications for radial access cases involving pressure-wire studies. (J Am Coll Cardiol Intv 2015;8:527–35)
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ABBR EV I A T I ON S
AND ACRONYMS
FFR = fractional ﬂow reserve
Pa = pressure aorta
PCI = percutaneous coronary
intervention
Pd = pressure distal
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528hyperemia in the vascular bed under investi-
gation (5). This is most commonly achieved
with adenosine, either given as an intra-
venous infusion or as an intracoronary
bolus. In many cases, an intravenous infu-
sion of adenosine is preferred to bolus
administration.
Transradial access for PCI is also rapidly
growing in popularity worldwide and has become the
predominant mode of access in many countries.
Accumulating evidence suggests a clinical beneﬁt,
particularly in higher risk settings such as acute cor-
onary syndrome and ST-segment elevation myocar-
dial infarction (6–8). In cases in which radial access is
used, the femoral area is not routinely prepared
with intravenous access via a peripheral vein in the
arm. In cases in which pressure-wire studies are
required, concerns exist over use of forearm (espe-
cially hand vein) administration, given the short
half-life of adenosine in relation to the venous
access site-to-heart transit time. De Bruyne et al. (9)
found that intravenous administration of adenosine
at 140 mg/kg/min was equally as effective as higher
doses in producing maximal hyperemia, and ante-
cubital venous access appeared to be as good as
femoral in this respect (forearm and hand vein access
was not studied). However, they do mention 3 cases
in which antecubital vein use led to “wide ﬂuctua-
tions of coronary resistance,” which were not seen
with a femoral approach. Femoral vein use was
therefore recommended where a pullback is required
(due to more stable steady-state conditions).
The purpose of this study was to compare central
versus peripheral adenosine infusion, both in the
assessment of peak FFR and stability of peak FFR
recording once achieved. To model frequent clinical
practice, we chose to compare the use of a small pink
(20-gauge) cannula in the back of the hand versus a
5- or 6-French sheath in the femoral vein.
METHODS
This study was carried out at a single regional cardiac
center in the United Kingdom. Patients who were to
undergo elective pressure-wire study or for possible
ad hoc pressure-wire study during diagnostic angi-
ography were considered for inclusion in the study.
Ethics approval was granted from the institutional
ethics review process, and informed patient consent
was obtained.
CLINICAL PROTOCOL. Patients had intravenous access
established before the pressure-wire procedure using
a pink (20-gauge) cannula placed in the hand or, inthe occasional case in which no suitable hand vein
was found, at wrist level (but no more proximally
in the arm than this). Coronary angiography was
performed as per usual clinical protocol. The radial
or femoral route of arterial access was chosen
based on individual operator preference. For femoral
venous administration of adenosine, a venous sheath
(5- or 6- F) with a side arm was used. The Radi
PressureWire system (St. Jude Medical, St. Paul,
Minnesota) was used in all cases.
Based on usual clinical criteria (10), coronary
lesions thought to require further evaluation by a
pressure-wire procedure were studied as follows. 1)
A pressure wire was passed in the usual manner, with
equalization in the proximal portion of the vessel
followed by passage distal to the lesion of interest. 2)
Adenosine was ﬁrst administered via the hand can-
nula at a rate of 140 mg/kg/min for 2 min. Tracings
were recorded from the time of commencement of
adenosine infusion. 3) After 2 min of adenosine
infusion in the hand, the adenosine was stopped. At
least 1 min was allowed to pass, allowing resting
pressure distal/pressure aorta (Pd/Pa) distal to the
lesion to return to baseline (pre-adenosine) levels.
The wire position was not altered during this time
(i.e., no pullback was performed at this stage).
4) Adenosine was then administered via the femoral
venous sheath at a rate of 140 mg/kg/min. A new
tracing was recorded from the time of commence-
ment of this adenosine infusion for 2 min. 5) At the
end of this time, pullback to the guide catheter was
performed to exclude signiﬁcant drift (and localize
the area of step-up if required).
ANALYSIS PROTOCOL. Intracoronary pressure re-
cordings were downloaded from the relevant cath-
eter laboratory hardware (Radi Analyzer, St. Jude
Medical) and viewed on RadiView software. Review
of all tracings was performed by a highly experienced
cardiac physiologist who was blinded to route of
administration of adenosine and to all procedural
details.
For each tracing, the full 2-min recording was
examined, and the period of lowest stable Pd/Pa
readings was taken to reﬂect maximal hyperemia. Ten
consecutive beats were averaged during this period
to derive FFR (5 beats on either side of the point of
lowest Pd/Pa) to counteract ﬂuctuation in FFR mea-
surement and ensure that a smooth recording was
obtained. The time to peak hyperemia was taken as
the time to the lowest stable Pd/Pa value.
ASSESSMENT OF STABILITY OF PEAK FFR. To assess
stability of hyperemia, the next 30 s of tracing sub-
sequent to the period of maximal hyperemia was
TABLE 1 Baseline Data of Study Patients
No. of patients 61
No. of vessels 84
Mean age, yrs 64.5
Mean weight, kg 83
Mean height, cm 172
Male 46 (75)
Clinical setting
Stable angina 52 (85)
Acute coronary syndrome 9 (15)
Vessels attempted
LAD/diagonal 45 (54)
LCx/marginal 19 (23)
RCA/PDA 16 (19)
Ramus 2 (2)
LMS 1 (1)
LIMA graft 1 (1)
FFR
Hand, SD 0.85  0.076
Femoral, SD 0.85  0.078
Femoral FFR - hand FFR 0.08 to 0.04
Femoral FFR - hand FFR 0 (0.01 to 0.01)
Mean time to peak hyperemia, s
Hand 67
Femoral 44
Stability Index
Hand 0.016
Femoral 0.014
Values are n, n (%), mean  SD, range, or mean (interquartile range).
FFR ¼ fractional ﬂow reserve; LAD ¼ left anterior descending artery; LCx ¼ left
circumﬂex artery; LIMA ¼ left internal mammary artery; LMS ¼ left main stem
artery; PDA ¼ posterior descending artery; RCA ¼ right coronary artery.
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529evaluated. A 30-s period was chosen as it was thought
that clinical pullback measurements would usually
be completed within this time and the relevant period
of recording in which to assess stability and its po-
tential impact on lesion assessment. The highest
value of Pd/Pa over this 30-s period was identiﬁed,
and a 3-beat average around this point was calcu-
lated. The use of a 3-beat average ensured that the
degree of Pd/Pa ﬂuctuation was faithfully captured
rather than being “smoothed out” by averaging over a
larger number of beats. A stability index was calcu-
lated simply as (highest 3-beat average of Pd/Pa dur-
ing 30 s after maximal hyperemia)  (FFR, that is, the
10-beat average of Pd/Pa at peak hyperemia).
STATISTICAL ANALYSIS. Statistical analysis was
performed using GraphPad Prism (Graphpad Software
Inc., La Jolla, California). Bland-Altman analysis was
used to compare the 2 routes of adenosine adminis-
tration in terms of steady-state FFR obtained (11).
For time to peak hyperemia and stability index,
paired nonparametric testing was performed (based
on the ﬁndings of non-Gaussian distributions for
these parameters).
RESULTS
PATIENT AND DEMOGRAPHIC CHARACTERISTICS.
Paired (hand and femoral adenosine) recordings
taken from 84 vessels in 61 patients were suitable for
blinded analysis. The mean age was 64.5  10 years
(range 39 to 86 years), and sex ratio was 46 (75%)
male to 15 (25%) female. Additional baseline and
procedural data are summarized in Table 1.
Figure 1 illustrates a typical example of a tracing
reviewed on the RadiView software system. The re-
gion of steady-state maximal hyperemia is shown, as
is the area of highest Pd/Pa over the subsequent 30 s.
EXTENT OF HYPEREMIA. The mean FFR measured
using the hand and femoral routes of adenosine
administration was 0.85 with an SD of 0.08.
Figure 2 is a before-and-after plot for each FFR
hand recording and subsequent comparable FFR
femoral recording, revealing very similar FFR output
for the majority of cases. Figure 3A illustrates corre-
sponding steady-state FFR measurements for each
lesion as (x,y) coordinates. The line of identity is
shown as a solid line on this graph. The majority of
readings lie close to this line, indicating a good
agreement between FFR values derived from the
2 routes of adenosine administration (intraclass
correlation ¼ 0.986; p < 0.001). Figure 3B shows a
Bland-Altman plot of the same data and allows easier
visualization of the direction of disagreementbetween FFR from the 2 routes. Many cases exist in
which the steady-state FFR is actually lower using
hand vein adenosine infusion than when using the
femoral venous sheath (represented as data points
below the x-axis on the graph). There are similarly
many other cases in which the converse is true (i.e.,
FFR from femoral adenosine administration is lower).
Formal evaluation of the agreement between these
2 measures of FFR by Bland-Altman analysis indi-
cated an estimated bias of 0.002 with 95% limits of
agreement extending from 0.03 to þ0.04, with no
evidence for a systematic direction of bias of FFR
measurements from the 2 different routes.
In patients undergoing assessment of more than
1 coronary stenosis, the route of adenosine adminis-
tration producing the lowest value of steady-state
FFR could vary among lesions. Figure 4 shows an
expanded portion of Figure 3A centered on the clinical
threshold FFR value of 0.80. Given the similar FFR
values produced by the 2 routes of adenosine admin-
istration and the lack of systematic bias between
these, it is an inevitable consequence that the use of a
strict cutoff value (such as the widely used FFR#0.80)
FIGURE 1 Fractional Flow Reserve Recording in a Sample Patient
A typical example of a tracing reviewed on the RadiView software system (St. Jude Medical, St. Paul, Minnesota). The region of steady-state maximal hyperemia
(ﬁrst yellow bar labeled A) is shown, as is the area of highest pressure distal (Pd)/pressure aortic (Pa) over the subsequent 30 s (subsequent yellow bar labeled B).
The stability index in this case is þ0.01. FFR ¼ fractional ﬂow reserve.
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530for decision making will lead to cases when a dif-
ferent decision would be made depending on whether
adenosine was administered via hand vein or femoral
vein routes. This is illustrated graphically in Figure 4,
which shows 5 cases (enclosed by a square on the
graph) in our study in which FFR was positive with
hand vein adenosine infusion but negative with fem-
orally administered adenosine. Conversely, 4 cases in
which the FFR was negative with hand vein aden-
osine infusion but positive with femorally adminis-
tered adenosine (enclosed by oval on the graph) are
also highlighted. No cases had a signiﬁcant crossover
difference in FFR from 1 side of the gray zone (0.76 to
0.80) to the other (i.e., no value dropped from an
FFR of >0.8 with hand adenosine to <0.76 with a
femoral adenosine). Similarly, no value rose from a
FFR of <0.76 with hand vein adenosine infusion to
more than 0.8 with femorally administered adenosine
(Figure 2). The clinical implications of this ﬁnding are
considered further in the Discussion section.RAPIDITY OF HYPEREMIA. Time to peak hyperemia
was longer with hand compared with femoral aden-
osine (67 s vs. 44 s; p < 0.001). In Figure 5, data points
lie mainly on the right-hand side of the line
of identity, indicating that the time to peak
hyperemia was shorter with the femoral route of
adenosine administration than with the hand vein
adenosine infusion, whereas in rare cases, the con-
verse was true. In patients in whom more than 1
lesion was assessed, it was found that 1 particular
route of adenosine administration was consistently
more rapid in achieving steady state than the other,
and the times to peak hyperemia from any particular
route were remarkably consistent in an individual
patient. In 1 patient, the development of hyperemia
with hand vein adenosine infusion was delayed such
that there was no change from resting Pd/Pa value
(distal to the lesion) until almost 2 min of adenosine
infusion had elapsed. The recording was continued
beyond 2 min in this case, and peak hyperemia was
FIGURE 2 Before and After Plot Comparing FFR Hand
and Subsequent FFR Femoral Infusion for Each Recording
No cases of FFR >0.85 with hand adenosine infusion were
<0.80 using the femoral route of infusion or vice versa. Also, no
cases had a signiﬁcant crossover difference in FFR from 1 side of
the gray zone (0.76 to 0.80) to the other (i.e., no value dropped
from a FFR of >0.8 with hand adenosine infusion to <0.76 with
femoral adenosine infusion). Similarly, no value rose from an FFR
of <0.76 with hand adenosine infusion to >0.8 with femoral
adenosine infusion. FFR ¼ fractional ﬂow reserve.
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531noted at 147 s in this case compared with 54 s from
the groin. When a second lesion was assessed in this
patient, times to hyperemia from the hand and groin
were 140 s and 53 s, respectively (highlighting the
consistency in time to hyperemia for each route and
eliminating any concern that the ﬁrst delayed hy-
peremic result from the hand was artifact due to
“dead space” in the adenosine infusion line).FIGURE 3 Comparison of Hand and Femoral Adenosine Infusions on
(A) Corresponding steady-state FFR measurements for each lesion as (x,
The line of identity (for an exact match between the 2 readings) is shown
of the direction of disagreement between FFR from the 2 routes. FFR ¼STABILITY OF HYPEREMIA. The stability of Pd/Pa
readings with ongoing adenosine infusion via hand
versus femoral routes is indicated in Figure 6. Paired
pullback recordings were available in 75 cases.
The solid line in Figure 6A represents the line of
identity, and the scatter of data points on either side
of this line demonstrates that the stability of readings
may be greater with either route on an individual
basis. Data points on the line of identity represent
cases in which stability was equivalent from either
approach. Figure 6B shows the summarized data for
stability for all cases. Formal comparison using Mann-
Whitney analysis (2-tailed) gives a p value of 0.43,
indicating no signiﬁcant evidence of a difference in
stability between the 2 routes.
DISCUSSION
Transradial access has become standard practice
in many European countries and is rapidly gaining
popularity in the United States. Use of the pressure-
wire test for FFR-guided decision making has an
established evidence base from large contemporary
randomized trials, and its use is increasing world-
wide. The use of a combination of transradial access
and FFR-based lesion assessment is rapidly becoming
a standard of care in many clinical situations, and
the issue of adenosine delivery is therefore relevant
and topical. Complete avoidance of femoral site ac-
cess in a transradial case is highly desirable and has
led to frequent use of peripheral venous adenosine
administration for FFR, despite lingering doubts asFFR Recordings
y) coordinates (i.e., hand infusion route of adenosine (x-axis) versus the femoral route (y-axis).
as a solid line on this graph. (B) A Bland-Altman plot of the same data allows easier visualization
fractional ﬂow reserve.
FIGURE 4 Different FFR Results From Different Access Points
Five cases (represented by a red squares on the graph) in our study in which FFR was
positive with hand adenosine infusion but negative with femoral adenosine infusion.
Conversely, 4 cases in which the FFR was negative with hand adenosine infusion but
positive with femoral adenosine infusion (represented by blue squares on the graph) are
also highlighted. FFR ¼ fractional ﬂow reserve.
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532to whether a small cannula would actually generate
adequate and sufﬁciently stable coronary hyperemia
compared with a central venous infusion.
In this study, close but not identical agreement was
found between FFR values obtained using adenosine
administered via the hand and femoral routes, and
no systematic direction of bias was evident from
Bland-Altman analysis. These 2 ﬁndings taken to-
gether lead to the inevitability of cases in which the
2 routes will produce slightly different FFR valuesFIGURE 5 Time to Peak Hyperemia
(A) The 2 routes of adenosine infusion are shown for individual cases as
(B) The mean times to peak hyperemia with hand and femoral adenosinthat happen to lie on opposite sides of the usual
decision threshold of FFR #0.80. It has been well
documented that intrinsic variability of FFR re-
cordings does exist when repeated on the same
lesion, with the DEFER study showing only 80%
certainty (probability that the FFR-guided revascu-
larization strategy will not change if the test is
repeated 10 min later) at an FFR range of 0.77 to 0.83
(12). The occasional FFR difference between access
routes may actually be due to the intrinsic variability
of the test itself and independent of whether adeno-
sine is administered via the back of the hand or groin.
This could also explain the other interesting ﬁnding
in our study, where the access route of adenosine
infusion producing the lowest value of steady-state
FFR could vary between lesions in the same patient
undergoing assessment of more than 1 coronary
stenosis.
Our ﬁndings support a strategy of using peripheral
venous adenosine administration as the default
approach (including use of the veins in the hand, if
more proximal access in the forearm or antecubital
fossa is difﬁcult). The close agreement of FFR using
hand and femoral routes (with 95% conﬁdence in-
tervals extending to differences of 0.03 to þ0.04)
indicate that if FFR using peripheral route adenosine
administration is$0.85, then the value obtained using
central (femoral) route for adenosine administration in
this case is unlikely to be#0.80. Indeed, no such cases
were demonstrated in our study, as seen in Figure 2.
In cases involving the so-called gray zone (0.76
to 0.80), prudent clinical judgment is advised. Pre-
vious suggestions for dealing with borderline FFR
results such as this include the administration of
higher doses of adenosine by infusion or an added(x,y) coordinates. The straight red line indicates the line of identity.
e infusion. FFR ¼ fractional ﬂow reserve.
FIGURE 6 Paired Stability Indexes
Stability index (highest 3-beat average of pressure distal/pressure aortic [Pd/Pa] during 30 s after maximal hyperemia) minus (FFR) with hand
versus femoral infusion routes (A). The solid line represents the line of identity. (B) The mean SI data for stability for all cases; the mean SI
for hand infusion is 0.016 and 0.014 for groin infusion. FFR ¼ fractional ﬂow reserve; CI ¼ stability index.
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533intracoronary bolus (in an effort to ensure maximal
hyperemia has been achieved). The former approach
has been shown in a single study to produce signiﬁ-
cantly lower FFR recordings when comparing an
adenosine infusion rate of 140 mg/kg/min with a rate
of 170 mg/kg/min via the antecubital fossa (13). This
study was limited by minimal (0.0064, 95% conﬁ-
dence interval: 0.0004 to 0.0124, p ¼ 0.038) absolute
FFR differences between the 2 infusion rates, and
steady-state FFR recordings of more than 10 beats
were not performed. Indeed, increasing adenosine
rates to more than 140 mg/kg/min failed to produce
incremental hyperemia when formally studied in 2
further randomized, controlled trials (9,14). As such,
the routine practice at our center is to infuse at
140 mg/kg/min from both central and peripheral ac-
cess routes. The latter approach (intracoronary bolus
while the intravenous adenosine infusion still
running) was assessed in a subgroup of patients in a
recent Korean study where it failed to improve hy-
peremic efﬁciency but was nevertheless associated
with an increased risk of prolonged atrioventricular
block (15).
An alternate suggestion when faced with a bor-
derline FFR recording has been to switch to central
venous access, if a peripheral adenosine infusion has
initially been used. This approach is often based on
subjective conjecture, not evidence based and
certainly not supported by the results of this study.
Indeed, 5 cases of peripherally infused adenosine
produced FFR results <0.80 compared with central
administration results of >0.80 (Figure 4).Time to hyperemia was longer on average with
hand compared with femoral adenosine administra-
tion. This additional time required for hyperemia
with hand route of adenosine administration will
not produce signiﬁcant intraprocedural delay, par-
ticularly when contrasted with time to establish
femoral venous access. One caveat with hand route
of adenosine administration relates to occasional
cases in which there is a long delay before any
change in resting Pd/Pa after adenosine infusion
commencement (encountered in 1 of our study cases,
as described earlier). In this situation, adenosine
infusion must be continued for a longer duration to
allow the development of hyperemia. Once steady
state is achieved in this manner, the degree of hy-
peremia appears comparable to that with the femoral
route.
Finally, the ﬁndings regarding stability of hyper-
emia with hand and femoral adenosine infusion are
reassuring. Although not standard practice, we used
a 10-beat average for obtaining FFR to ensure that
any potential ﬂuctuation in recordings were negated
as much as possible and allow adequate assessment
of the stability index. The results indicate that hand
adenosine infusion should provide comparable sta-
bility, and femoral venous access need not be con-
sidered a requirement in situations in which a
pullback tracing is desired. The degree of variability
in the FFR readings was noted to be markedly
different between individuals, with some having
virtually no variability once at steady state, and
others having a notably cyclical change in Pd/Pa over
PERSPECTIVES
WHAT’SKNOWN?Fractional ﬂow reserve (FFR) is a
well-established tool for physiological assessment of
the severity of a coronary artery stenosis. Maximal
hyperemia is required for optimal FFR-guided lesion
assessment, usually via administration of adenosine.
Debate remains as to whether optimal adenosine
infusion to achieve stable, maximal hyperemia should
be via a central venous line, or will peripheral
administration via a small cannula will sufﬁce?
WHAT’S NEW? This study provides reassurance
about the use of hand vein adenosine infusion to
generate maximal coronary hyperemia for the
assessment of FFR. Converting to femoral access for
adenosine infusion is not supported by this study, and
any divergence seen on the FFR result by switching
access site could simply be explained by the variability
of the index procedure itself.
WHAT’S NEXT? This study is not able to comment
on the potential utility of higher doses of adenosine
infusion or systematic use of an intracoronary bolus
(added to intravenous infusions) in the assessment of
FFR. Future research could assess infusion of adeno-
sine from differing peripheral access sites (e.g., back
of the hand, wrist, forearm, antecubital fossa) or
whether body habitus plays an important role.
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534time (the so-called accordion effect). In this latter
group, this phenomenon was noted with both hand
and femoral adenosine infusion (to variable relative
extents in individual patients, as indicated in
Figure 6). This is often considered a potential short-
coming restricted only to the peripheral venous
approach (9); however, in line with previous small
studies, our results have disputed this (16).
STUDY LIMITATIONS. This study is not able to
comment on the potential utility of higher doses of
adenosine infusion or systematic use of an intra-
coronary bolus (added to intravenous infusions) in
the assessment of FFR. Also, the FFR procedures were
performed by several operators at a single center, and
interobserver variability was not assessed. However,
individual operator technique was formalized using
local and study guidelines, and data analysis was
performed by a blinded clinical physiologist. We did
not compare infusion of adenosine from differing
peripheral access sites (e.g., back of the hand, wrist,
forearm, antecubital fossa) or determine whether
body habitus played an important role, and this may
be an opportunity for future research.
CONCLUSIONS
This study provides reassurance about the use of
hand vein adenosine infusion to generate maximal
coronary hyperemia, including situations in which
information from a pullback is required. When FFR
recordings in and around the gray zone (0.76 to
0.80) are obtained, converting to femoral access
for adenosine infusion is not supported, and any
divergence seen on the FFR result by switching ac-
cess site could simply be explained by the variability
of the index procedure itself. Additional hyperemic
stimulus with intracoronary adenosine is a more
appropriate option in addition to sound clinical
judgment, with the decision to revascularize basedon the evaluation of each individual patient and his
or her symptoms.
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